Evidence map›Paper›PMID 30089694›Full record

ArticleJournal of virology2018

PF74 Reinforces the HIV-1 Capsid To Impair Reverse Transcription-Induced Uncoating.

Sanela Rankovic, Ruben Ramalho, Christopher Aiken, Itay Rousso

Abstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Quinazolinone-based Subchemotypes for Targeting HIV-1 Capsid Protein: Design and Synthesis.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2024
    Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sanela RankovicBen-Gurion University of the Negev, Department of Physiology and Cell Biology, Beer Sheva, Israel.
Ruben RamalhoBen-Gurion University of the Negev, Department of Physiology and Cell Biology, Beer Sheva, Israel.
Christopher AikenVanderbilt University Medical Center, Department of Pathology, Microbiology and Immunology, Nashville, Tennessee, USA.
Itay RoussoBen-Gurion University of the Negev, Department of Physiology and Cell Biology, Beer Sheva, Israel roussoi@bqu.ac.il.ORCID https://orcid.org/0000-0002-4399-9171

Funding

A Competition Binding Assay for Identifying Novel HIV-1 Capsid LigandsR01AI114339 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI AIKEN, CHRISTOPHER R · 2014 to 2016
$1.1M
NIAID NIH HHS R01 AI114339
6 · The paper itself

Abstract

The RNA genome of human immunodeficiency virus type 1 (HIV-1) is enclosed in a cone-shaped capsid shell that disassembles following cell entry via a process known as uncoating. During HIV-1 infection, the capsid is important for reverse transcription and entry of the virus into the target cell nucleus. The small molecule PF74 inhibits HIV-1 infection at early stages by binding to the capsid and perturbing uncoating. However, the mechanism by which PF74 alters capsid stability and reduces viral infection is presently unknown. Here, we show, using atomic force microscopy (AFM), that binding of PF74 to recombinant capsid-like assemblies and to HIV-1 isolated cores stabilizes the capsid in a concentration-dependent manner. At a PF74 concentration of 10 μM, the mechanical stability of the core is increased to a level similar to that of the intrinsically hyperstable capsid mutant E45A. PF74 also prevented the complete disassembly of HIV-1 cores normally observed during 24 h of reverse transcription. Specifically, cores treated with PF74 only partially disassembled: the main body of the capsid remained intact and stiff, and a cap-like structure dissociated from the narrow end of the core. Moreover, the internal coiled structure that was observed to form during reverse transcription

Indexed as

Antiviral AgentsCapsidHIV-1IndolesMicroscopy, Atomic ForcePhenylalanineProtein BindingReverse TranscriptionVirus UncoatingAntiviral AgentsIndolesPF-3450074Phenylalanineatomic force microscopycapsidHIV-1PF74reverse transcriptionuncoating

Identifiers

PMID30089694
PMCPMC6158434

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.